Regeneron Pharmaceuticals' Other Working Capital Changes fell 24972.88% to -$82.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $375.3 million, marking a year-over-year decrease of 790.18%. This contributed to the annual value of $375.3 million for FY2025, which is 790.18% down from last year.
Latest data reveals that Regeneron Pharmaceuticals reported Other Working Capital Changes of -$82.8 million as of Q4 2025, which was down 24972.88% from $47.9 million recorded in Q3 2025.
Regeneron Pharmaceuticals' 5-year Other Working Capital Changes high stood at $487.3 million for Q2 2024, and its period low was -$252.0 million during Q3 2024.
Moreover, its 5-year median value for Other Working Capital Changes was $41.9 million (2021), whereas its average is $64.6 million.
In the last 5 years, Regeneron Pharmaceuticals' Other Working Capital Changes skyrocketed by 832800.0% in 2021 and then tumbled by 77860.96% in 2023.
Over the past 5 years, Regeneron Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$76.1 million in 2021, then soared by 75.43% to -$18.7 million in 2022, then plummeted by 778.61% to -$164.3 million in 2023, then surged by 133.66% to $55.3 million in 2024, then tumbled by 249.73% to -$82.8 million in 2025.
Its Other Working Capital Changes was -$82.8 million in Q4 2025, compared to $47.9 million in Q3 2025 and $230.7 million in Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value